Can we successfully define and target BRCA-like breast cancers?

Transl Cancer Res. 2024 Jan 31;13(1):1-5. doi: 10.21037/tcr-23-577. Epub 2024 Jan 29.

Authors

Nathalie LeVasseur^{1

2}, Karen A Gelmon^{1

2}

Affiliations

¹ Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
² Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

No abstract available

Keywords: BRCA-like; Poly (ADP-ribose) polymerase (PARP); biomarker; homologous recombination deficiency (HRD); veliparib.

Publication types

Editorial
Comment